CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in NVAX — Novavax Inc
CIK 884546
SAN FRANCISCO, CA
Position in NVAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,685,037
+$1,504,707 QoQ
Shares Held
1,346,607
-2.0% QoQ
Ownership
0.816%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 263 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,344,284,536 across 299 Biotechnology names. NVAX ranks #97 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in NVAX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,685,037 | 1,346,607 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,180,330 | 1,373,505 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,971,556 | 1,335,053 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,542,249 | 1,331,286 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $8,303,910 | 1,318,081 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $8,622,347 | 1,345,140 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $10,977,928 | 1,365,414 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $16,741,166 | 1,325,508 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $14,406,573 | 1,137,960 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,446,451 | 930,220 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,649,598 | 760,333 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $5,092,254 | 703,350 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,844,924 | 652,076 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,157,197 | 455,584 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,284,179 | 416,749 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,400,848 | 406,640 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,793,869 | 404,314 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $28,370,274 | 385,204 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $54,771,917 | 382,833 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $76,787,002 | 370,397 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $71,790,715 | 338,141 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $83,377,579 | 459,862 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $44,033,626 | 394,885 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $41,360,012 | 381,726 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $33,196,304 | 398,276 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $3,823,598 | 281,561 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||